computed tomography (ct) and magnetic resonance imaging (MRi) can quantify muscle mass and quality. However, it is still unclear if ct and MRi derived measurements can be used interchangeable. In this prospective study, fifty consecutive participants of a cancer screening program underwent same day low-dose chest ct and MRi. cross-sectional areas (cSA) of the paraspinal skeletal muscles were obtained. CT and MRI muscle fat infiltration (MFI) were assessed by mean radiodensity in Hounsfield units (HU) and proton density fat fraction (MRi pDff), respectively. cSA and Mfi were highly correlated between CT and MRI (CSA: r = 0.93, P < 0.001; MFI: r = − 0.90, P < 0.001). Mean CSA was higher in CT compared to MRI (46.6cm 2 versus 43.0cm 2 ; P = 0.05) without significance. Based on MRI pDff , a linear regression model was established to directly estimate skeletal muscle fat content from ct. Bland-Altman plots showed a difference between measurements of − 0.5 cm 2 to 7.6 cm 2 and − 4.2% to 2.4% regarding measurements of cSA and Mfi, respectively. in conclusion, the provided results indicate interchangeability of ct and MRi derived imaging biomarkers of skeletal muscle quantity and quality. comparable to MRi pDff , skeletal muscle fat content can be quantified from CT, which might have an impact of analyses in larger cohort studies, particularly in sarcopenia patients. Decrease in skeletal muscle quantity and quality, commonly termed sarcopenia, is known as a strong risk factor for adverse outcomes in several chronic and malignant diseases. Sarcopenia was shown to have high socioeconomic and personal burden and leads to impaired activity in daily life, decreased mobility, loss of independency and a higher mortality 1-3. Initially, sarcopenia was considered to be an age-related phenomenon 4. However, it is now increasingly realized that sarcopenia may also occur in younger patients, for example secondary due to systemic diseases. Moreover, it was realized that sarcopenia may not be captured by conventional anthropometric measurements such as body mass index (BMI) or waist-to-hip-ratio, particularly in obese patients 1,5. Amount and quality of skeletal muscles can be assessed by cross-sectional imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). Previous studies indicate that both modalities may provide imaging based quantitative biomarkers of sarcopenia, and that these biomarkers may reveal prognostic information in various severe diseases 6-10. Thereby, cross sectional areas (CSA) of skeletal muscles at distinct anatomical landmarks were shown to provide accurate surrogates of total skeletal muscle amount and therefore may be used to identify patients with low muscle mass 1,6,7. The most common approaches to estimate skeletal muscle amount are determination of circumferential skeletal muscle area or psoas muscle area, both typically obtained at lumbar vertebral levels 1. However, these landmarks are frequently not captured in several imaging protocols, although sarcopenia is known to b...
Background: Lateral extra-articular tenodesis (LET) is being increasingly added to primary and revision anterior cruciate ligament (ACL) reconstruction to address residual anterolateral rotatory instability. However, currently there is a lack of knowledge on how close the femoral tunnels are when combining these procedures. Purpose/Hypotheses: To assess the risk of tunnel convergence in combined ACL and LET procedures using 2 different surgical techniques (Lemaire and MacIntosh). It was hypothesized that the risk of tunnel convergence would be greater when using the more distally located Lemaire position. The authors further hypothesized that tunnel proximity would be influenced by knee size. Study Design: Controlled laboratory study. Methods: Ten fresh-frozen cadaveric knees were used for this study. In each specimen, an anatomic ACL femoral tunnel and 2 LET tunnels were drilled using the Lemaire and MacIntosh positions, respectively. After knee dissection, minimal distances between each ACL and LET tunnel were directly measured on the lateral femoral cortex. Furthermore, computed tomography scans were obtained to measure intertunnel convergence and lateral femoral condyle (LFC) width. On the basis of the average LFC width, knees were divided into large and small knees to determine a relationship between knee size and tunnel convergence. Results: Convergence of ACL and LET tunnels occurred in 7 of 10 cases (70%) using the Lemaire attachment position. All tunnel collisions occurred directly on the lateral femoral cortex, while intertunnel (intramedullary) conflicts were not observed. Collisions emerged in both small (n = 4) and large (n = 3) knees. Critical tunnel convergence did not occur using the MacIntosh position. The mean minimal distance between the LET and ACL tunnel using the Lemaire and MacIntosh positions was 3.1 ± 4.6 mm and 9.8 ± 5.4 mm, respectively. Conclusion: Tunnel convergence was more frequently observed in combined ACL and LET reconstruction using the Lemaire technique, independent of the knee size. LET femoral tunnel positioning according to the MacIntosh reconstruction was not associated with tunnel collision. Clinical Relevance: These findings help to raise the awareness for the risk of tunnel convergence in combined ACL and LET procedures. Surgeons may contemplate adjustments on the ACL femoral tunnel drilling technique or fixation device when applying an additional Lemaire procedure. However, in the absence of clinical outcome studies comparing different LET techniques, it remains unclear which technique is superior in a clinical setting.
• Chemical-shift-encoding based water-fat MRI can reliably assess vertebral bone marrow PDFF • PDFF is significantly higher in acute benign than in malignant VCFs • PDFF provides high accuracy for differentiating acute benign from malignant VCFs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.